Why is Synthesis Inhibition Important in Neonatal Disorders?
Neonates are particularly vulnerable to metabolic and genetic disorders due to their immature organ systems and rapidly developing bodies. Inhibiting the synthesis of harmful substances can prevent complications such as neurological damage, organ failure, and developmental delays. For instance, in conditions like Phenylketonuria (PKU), inhibiting the synthesis of phenylalanine can prevent severe cognitive impairments.
